IJSTR

International Journal of Scientific & Technology Research

IJSTR@Facebook IJSTR@Twitter IJSTR@Linkedin
Home About Us Scope Editorial Board Blog/Latest News Contact Us
CALL FOR PAPERS
AUTHORS
DOWNLOADS
CONTACT
QR CODE
IJSTR-QR Code

IJSTR >> Volume 7 - Issue 10, October 2018 Edition



International Journal of Scientific & Technology Research  
International Journal of Scientific & Technology Research

Website: http://www.ijstr.org

ISSN 2277-8616



Outcome Of Early Vs Late Antibiotic Administration In Management Of Patients With Severe Sepsis

[Full Text]

 

AUTHOR(S)

Shaheer Zahid

 

KEYWORDS

Sepsis, Antibiotic administration in the management of severe sepsis, microbial isolate from infection, site of infection, the mortality rate in sepsis, organ failure from sepsis.

 

ABSTRACT

Sepsis is a potentially life-threatening complication of an infection. Sepsis occurs when chemicals released into the bloodstream to fight the infection trigger inflammatory responses throughout the body. This inflammation can trigger a cascade of changes that can damage multiple organ systems, causing them to fail. With the increasing population at risk of sepsis in the United States, it has become crucial to recognize signs and symptoms of sepsis; also important is to refine and develop guidelines that will reduce the mortality. This study focused on the patients of Jackson Park hospital in the ER/ICU/Floors between Jan 1, 2014, and Dec 31, 2014, and compared the appropriateness of antibiotics, their administration time, microbial isolate and site of infection to the mortality rate seen amongst the patients. All the collected data were compared using tables, pie chart and bar graphs. The study showed patients receiving antibiotics within 3 hours of arrival to the ED had a reduction in mortality by 49% with sepsis from E. coli, MRSA & other staph infections were among the most common infections leading to mortality among the patients. Lungs and UTI infections were the most common site, with respiratory tract having 27% mortality among all patients presenting with sepsis. The study allowed a prompt evaluation of sepsis screening protocol, as well as developing new protocols to include certain antibiotics readily available in the ED and antibiogram to be done for all sepsis patients.

 

REFERENCES

[1] Bone RC, Balk RA, Cerra FB. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992. 101:1644-1655.

[2] Singer M, Deutschman CS, Seymour C, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810. doi:10.1001/jama.2016.0287.

[3] National Center for Health Statistics Data Brief No. 62 June 2011. Inpatient care for septicemia or sepsis: a challenge for patients and hospitals.Available at: http://www.cdc.gov/sepsis/datareports/index.html [Accessed 22 June. 2016].

[4] Mayr FB, Yende S, Angus DC. Epidemiology of severe sepsis. Virulence. 2014;5(1):4-11. doi:10.4161/viru.27372.

[5] Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-54.

[6] Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1644-55.

[7] Wood KA, Angus DC. Pharmacoeconomic implications of new therapies in sepsis. PharmacoEconomics. 2004;22(14):895-906.

[8] Russell JA, Singer J, Bernard GR, et al. Changing pattern of organ dysfunction in early human sepsis is related to mortality. Crit Care Med 2000;28:3405-11.

[9] Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858-73.

[10] Gaieski, D., Mikkelsen, M., Band, R., Pines, J., Massone, R., & Furia, F. et al. (2010). Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department*. Critical Care Medicine, 38(4), 1045-1053. http://dx.doi.org/10.1097/ccm.0b013e3181cc4824

[11] Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-77.

[12] Russell, JA. Management of Sepsis. N Engl J Med 2006;355:1699-713.

[13] Bone RC. Sepsis and its complications: the clinical problem. Crit Care Med. 1994 Jul. 22(7):S8-11.

[14] Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013 Feb;41(2):580-637.

[15] Health Research & Educational Trust (2016, January). Severe Sepsis and Septic Shock Change Package: 2016. Chicago, IL: Health Research & Educational Trust. Accessed at www.hret-hen.org. [Accessed 22 June. 2016].

[16] Pennington TH; E. coli O157 outbreaks in the United Kingdom: past, present, and future. Infect Drug Resist. 2014 Aug 19;7:211-22. doi: 10.2147/IDR.S49081. eCollection 2014.

[17] Sara E. The Relationship between Antimicrobial Resistance and Patient Outcomes: Mortality, Length of Hospital Stay, and Health Care Costs. 2015 Sept ;2:S82-S89. doi: 10.1086/499406